Please use this identifier to cite or link to this item:
|Title:||PEMPHIGUS-VULGARIS - TREATMENT and EVOLUTION of 40 PATIENTS|
|Authors:||Porro, A. M.|
Castro, R. M.
Almeida, F. A.
Universidade Federal de São Paulo (UNIFESP)
|Citation:||Journal of Dermatological Treatment. London: Informa Healthcare, v. 6, n. 2, p. 99-102, 1995.|
|Abstract:||A retrospective study was conducted of 40 patients with pemphigus vulgaris seen in the period between 1965 and 1991. the time of follow-up of the patients ranged from 6 months to 25 years 8 months, with a mean of 4 years 10 months. the objective of the study was to assess the therapeutic response and evolution of the patients. All patients included in the study were treated with corticosteroids and 18 also received an adjuvant immunosuppressant. the maximum daily corticosteroid dose ranged 10 to 180 mg prednisone equivalent. Control of the pemphigus vulgaris was obtained in 37 (92.5%) of the 40 patients with a mean daily corticosteroid dose of 77.4 mg prednisone equivalent. After control, 54% of the patients relapsed. At the end of the study, 10 patients (25%) were without lesions and did not require treatment, 16 (40%) were without lesions and receiving treatment, 10 (25%) had lesions and were receiving treatment, 2 (5%) had died of unrelated causes, and 2 (5%) had died due to pemphigus vulgaris and/or its treatment, and in both of these the cause of death was septicaemia.|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.